Tributary Capital Management LLC Purchases 246,379 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Tributary Capital Management LLC boosted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 38.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 893,008 shares of the company's stock after buying an additional 246,379 shares during the period. Tributary Capital Management LLC owned approximately 1.94% of Avanos Medical worth $14,217,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of AVNS. JPMorgan Chase & Co. lifted its holdings in shares of Avanos Medical by 6.9% during the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock worth $1,672,000 after buying an additional 4,472 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Avanos Medical by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company's stock valued at $25,337,000 after purchasing an additional 16,065 shares during the period. Barclays PLC grew its position in shares of Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock worth $2,311,000 after purchasing an additional 78,583 shares in the last quarter. Zacks Investment Management bought a new position in shares of Avanos Medical during the third quarter worth approximately $335,000. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Avanos Medical in the third quarter valued at approximately $212,000. 95.17% of the stock is owned by institutional investors.

Avanos Medical Price Performance

Shares of NYSE:AVNS traded down $0.01 during midday trading on Friday, hitting $15.79. The stock had a trading volume of 1,296,047 shares, compared to its average volume of 514,244. The company's 50-day moving average price is $17.05 and its 200-day moving average price is $20.67. Avanos Medical, Inc. has a fifty-two week low of $14.98 and a fifty-two week high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $725.52 million, a P/E ratio of 46.43 and a beta of 0.99.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.